. - :- : , , , , , , 2014.1550 ,
http://www.ersnet.org/index.php/news/item/4130-550-people-across-europe-will-die-today-from-a-preventable-lung-disease.html22
. - , , , . GINA
- . .GOLD33 ..?
, ,
4 , , . : .. : . . . , , , . .
4 1 ( ) ( ) / - (PEF ili FEV1)< 80% GINA 20085 2006 . , . . :
66 7 , (2) 4 , 15-30 . 2- 2- + 2-a + 2-a ( ) A-IgE + + 1 2 3 4
5GINA Report 2008 (www.ginasthma.org) , 8 5 GINA Management
Approach Based on Control for Children Older than 5 Years,
Adolescents and Adults.(1) ICS.ICS/LABA ICS. 4, . , .
ReferenceGINA (www.ginasthma.org) 1 2 3 4 5GINA Report 2008
(www.ginasthma.org) , . (1) 2- 2- 9GOLD guidelines.
www.goldcopd.comGINA guidelines. www.ginaastma.com10
* * * 2 : , , , , .1037 .. ; , . Cromolyn Sodium Ventolin, .
: 110, 40 . . 93%. : pH 7,5, PaCO2 27, PaO2 75. 11 : ( 0,5 c3
Albuterol 3,0 cm3 0,9% NaCl 10 . PEF 125/250 .20 . PEF 230/360 .
24, 108. (Fluticasone 100-400 2 ) + 2-a (Salmeterol 50 2 ).1213
!
